Professional Documents
Culture Documents
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
TITLE: Pain management
1. DEFINITION:
1. Pain:
1.1. An unpleasant sensory and emotional experience associated with actual or potential tissue
damage or described in terms of such damage.
1.2. Pain is highly personal and subjective and is whatever the patient says it is, existing
whenever he/she says it does. Self-report of pain is considered the most reliable indicator of
pain.
1.3. Pain is often accompanied by emotional and spiritual responses, such as suffering or
anguish, and effective management should include measures to address these responses.
2. High Risk Pain Populations may include, but are not limited to:
2.4 Patients who speak a different language or come from a different culture.
2.5 Patients with: a history of or active substance abuse; difficulty in communicating; limited
financial resources, social supports or access to health care; cognitive or psychosocial
impairments; metabolic alterations; analgesic allergies; and chronic
3. Acute Pain:
Note: Acute pain episodes may be present in patients with chronic pain.
4. Chronic Pain :
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 1 / 8
KINGDOM OF SAUDI ARABIA المملكـة العربيـة السعوديـة
MINISTRY OF HEALTH وزارة الصحة
General Directorate of Health Affairs المديرية العامة للشؤون الصحية
Makkah Al-Mukarramah Region بمنطقة مكة المكرمة
AJYAD EMERGENCY HOSPITAL مستشــفى أجياد للطوارئ
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
4.1 Malignant or non-malignant pain that exists beyond its expected time frame for healing or
where healing may not have occurred. It is persistent pain that is not amenable to routine pain
control methods.
Note: Patients with chronic pain may have episodes of acute pain related to treatment,
procedures, disease progression or reoccurrence.
5. Pain Management:
6. Pain Screen :
6.1 A quantitative rating of the intensity of pain reported by the patient utilizing a
standardized instrument that has demonstrated reliability and validity.
7. Pain Assessment:
7.1 An evaluation of the cause of the patient’s pain including but not limited to: location,
intensity, frequency, duration of pain, aggravating and relieving factors, effects on activities of
daily living, sleep patterns and psychosocial aspects of the patient’s life ,and effectiveness of
current strategies.
The pain assessment includes the rating from the pain screen, and all observed nonverbal
behavior
2. PURPOSE / INDICATION:
1. Maintaining an optimal level of comfort and safety for critically ill patients is our
universal goal and the gold-standard for the practice of analgesia and sedation.
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
4. POLICY:
6. PROCEDURE:
6.1. Assessment:
6.1.1 All patients are assessed for pain on admission, then subsequently thereafter according to
the initial assessment finding.
•
The registered nurse performs an initial screening and assessment, using the appropriate
Admission Assessment Form and pain measurement tool(s)
• The physician performs an initial pain assessment for pain factors, history and physical.
6.1.2. Pain Measurement Tools
6.1.2.1 General areas for Adult and Paediatric patients use the Pain Scale of 0-10. If they cannot
understand or are unwilling to use the scale, the Wong Baker FACES pain rating scale is used.
6.1.2.2Specialized areas use pain scales appropriate to the population and age group. For
example, the Neonatal/Infant Pain Scale (NIPS), and the Wong Baker FACES pain rating scale.
6.1.2.3 When patients are not able to give any from of self-report of pain for whatever reason;
e.g., pharmacological/physiological paralysis, developmental level, persistent vegetative state,
severe mental retardation, visual and hearing impairment, the Nonverbal Paediatric/Adult Pain
Scale is used.
6.1.3 When pain is identified, a comprehensive assessment is performed and documented. This
assessment is appropriate to the patient’s age and measures pain intensity and quality, such as:
• Pain character
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 3 / 8
KINGDOM OF SAUDI ARABIA المملكـة العربيـة السعوديـة
MINISTRY OF HEALTH وزارة الصحة
General Directorate of Health Affairs المديرية العامة للشؤون الصحية
Makkah Al-Mukarramah Region بمنطقة مكة المكرمة
AJYAD EMERGENCY HOSPITAL مستشــفى أجياد للطوارئ
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
• Frequency
• Onset
• Location
• Duration
6.2. Re-Assessment:
6.2.1 Reassessment occurs with each new report of pain, at a suitable interval following any pain
control intervention (particularly if a new medication or dosage is involved), and at regular
intervals appropriate to individual person status.
6.2.2 Acute/chronic pain will be reassessed within 1 hour depending on the medication and/or
alternative treatment administered.
6.2.3 The physician is notified when the pain score ≥ 4 indicating the prescribed pain
management regimen, is not effective.
6.3. Interventions:
6.3.1 Analgesic and treatments are administered as prescribed by physician order. Analgesics
ordered by physicians are administered via the least invasive route possible.
6.3.2 Nurses routinely, with vital signs, evaluate the patient for effective pain management, and
pain relief in accordance with the following guidelines:
IV – reassess in 15 minutes
6.3.3 Non-pharmacological interventions, if needed, are offered and taught to the patient:
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
6.4.1 Geriatric:
• Drug metabolism is slower in the elderly due to decreased hepatic and renal function.
• At greater risk for drug-drug and drug-disease interactions due to multiple disease and
medications.
• Barriers to pain assessment include cognitive, visual, hearing and motor impairments.
• At risks for over and/or under treatment of analgesics:
a. NSAIDS increase the risk of renal toxicity.
b. Opioids have a higher peak and last longer leading to prolonged sedation and respiratory
depression.
6.4.2 Pediatrics:
6.5.1 Patient/family education begins after initial pain assessment with identified knowledge
deficit areas. When part of treatment, the patient/family is educated. About.
• Pain
• Other symptom
• All available and appropriate methods for managing pain and other symptoms.
6.5.2 The patient’s preference is considered in determining the method(s) used for pain
management.
6.5.3 The Interdisciplinary Patient/Family Education Record reflects the type of teaching
performed and the patient/family response.
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 5 / 8
KINGDOM OF SAUDI ARABIA المملكـة العربيـة السعوديـة
MINISTRY OF HEALTH وزارة الصحة
General Directorate of Health Affairs المديرية العامة للشؤون الصحية
Makkah Al-Mukarramah Region بمنطقة مكة المكرمة
AJYAD EMERGENCY HOSPITAL مستشــفى أجياد للطوارئ
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
6.5.4 The physician must be notified for multiple, different interventions that are not effective,
and/or patient/family does not demonstrate understanding and ability of education taught.
6.6.1 Staff who deliver direct patient care will receive education/training, regarding pain
assessment and management initially during new employee hospital orientation, and thereafter,
annually through mandatory hospital education.
6.7.1 Patient’s rights include as assessment and appropriate management of pain. This right is addressed in the Patient
Handbook provided to each patient upon admission to the hospital.
a. A therapeutic plan and goal of anesthesia should be established for each patient and communicated to
all caregivers to ensure consistent analgesic therapy.
b. Nursing staff work together with the patient and other healthcare providers to establish a goal for pain
relief and develop and implement a plan to achieve that goal.
stabilization of fractures and elimination of irritating physical stimulation are important to maintain
patient comfort.
6. 13. Opioids
a. If intravenous doses of an opioid analgesia are required, Fentanyl, Morphine
and Pethidine are the recommended agents.
b. Scheduled opioid doses or a continuous infusion is preferred over an “as
needed” regimen to ensure consistent analgesia. A patient-controlled analgesia (PCA)
device may be utilized to deliver opioids if the patient is able to understand and operated
the devices and if the device is available.
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 6 / 8
KINGDOM OF SAUDI ARABIA المملكـة العربيـة السعوديـة
MINISTRY OF HEALTH وزارة الصحة
General Directorate of Health Affairs المديرية العامة للشؤون الصحية
Makkah Al-Mukarramah Region بمنطقة مكة المكرمة
AJYAD EMERGENCY HOSPITAL مستشــفى أجياد للطوارئ
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
c. Fentanyl is preferred for a rapid onset of analgesia is acutely distressed patients
in a dose of 1 micro gm/kg upto 100 micro gm.
d. Fentanyl is preferred for patients with haemodynamic instability or renal
insufficiency.
e. Morphine is preferred for intermittent therapy because of their longer duration
of effect. It is the preferred drug for cardiac pain as in myocardial infarction. Doses
recommended are 0.1 mg/kg and pethidine at 1mg/kg.
f. NSAIDs may be used as adjuncts to opioids in selected patients.
g. NSAID may be used via the central route in appropriate patients.
h. Assessment of pain intensity may be performed with unidimensional tools,
such as VRS, VAS, and NRS. NPS is recommended to assess pain in critically ill
patients.
0 1 2 3 4 5 6 7 8 9 10
The patient marks on the line the spot for the pain intensity, which is then measured. Non-written versions
can be used for very sick patients by having an attendant run a pencil along the line while the patient confirms
the point corresponding to the current pain.
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 7 / 8
KINGDOM OF SAUDI ARABIA المملكـة العربيـة السعوديـة
MINISTRY OF HEALTH وزارة الصحة
General Directorate of Health Affairs المديرية العامة للشؤون الصحية
Makkah Al-Mukarramah Region بمنطقة مكة المكرمة
AJYAD EMERGENCY HOSPITAL مستشــفى أجياد للطوارئ
• It is allowed ONLY to access and keep this document with its owner and to whom it is
applicable.
• It is NOT allowed to photocopy – in part or as a whole, and if needed, request it from its
owner to have a copy.
Pain Affect Faces Scale:
1 2 3 4 5 6 7
7. REFERENCES:
1. World Health Organization Briefing Note-Access to Controlled Medications Programme. Geneva., World Health
Organization, 2007.
2. Achieving balance in national opioids control policy, Guidelines for assessment. Geneva, World Health Organization,
2000
3. Guidelines For WHO Guidelines: Global Programme on Evidence for Health Policy (EIP/GPE/EQC/2003.1), Geneva,
World Health Organization, 2003.
Code MSD-PP-011 Issue No : 01 Issue Date: 01/05/1431 Activation Date:: 01/071431 Revision Date:: 30/04/1433 Copy No:
0 Page No: 8 / 8